Finance Watch: Many Mega-Rounds, Some Smaller VC Deals, But Few In The Middle

$100m-Plus Financings Leave Little For Mid-Sized Rounds

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.